| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10964469 | Vaccine | 2014 | 6 Pages |
Abstract
Due to the high fever rate experienced in the 20- and 60-μg groups, rLP2086 in the current formulation may not be acceptable for infants.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Federico Martinon-Torres, Francisco Gimenez-Sanchez, Enrique Bernaola-Iturbe, Javier Diez-Domingo, Qin Jiang, John L. Perez,